S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
RATIONALE: Serotonin (5-HT)(2C) receptors are implicated in the control of mood, and their blockade is of potential interest for the management of anxiodepressive states. OBJECTIVES: Herein, we characterized the in vitro and in vivo pharmacological profile of the novel benzourea derivative, S32006....
Κύριοι συγγραφείς: | Dekeyne, A, Mannoury la Cour, C, Gobert, A, Brocco, M, Lejeune, F, Serres, F, Sharp, T, Daszuta, A, Soumier, A, Papp, M, Rivet, J, Flik, G, Cremers, T, Muller, O, Lavielle, G, Millan, M |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2008
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.
ανά: Millan, M, κ.ά.
Έκδοση: (2004) -
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
ανά: Dekeyne, A, κ.ά.
Έκδοση: (2012) -
Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.
ανά: Karolina Pytka, κ.ά.
Έκδοση: (2015-01-01) -
Brain Targeting of Antidepressant and Anxiolytic Drugs
ανά: Jéssica Antunes, κ.ά.
Έκδοση: (2022-12-01) -
Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats
ανά: Wesołowska A, κ.ά.
Έκδοση: (2021-06-01)